According to Kaplan-Meier plotter, we found that a higher BTG3 expression was positively correlated with overall and progression-free survival rates of all cancer patients, even stratified by gender and Her2+ expression (Figure 1I and Table 1, p < 0.05). This evidence concerns the gene ERBB2 and cancer.